Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study

BACKGROUND: The lifetime risk of breast and ovarian cancer is significantly higher among women with genetic susceptibility or a strong family history. However, current risk assessment tools and clinical practices may identify only 10% of asymptomatic carriers of susceptibility genes. Bright Pink dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibler, Elizabeth A, Fought, Angela J, Kershaw, Kiarri N, Molsberry, Rebecca, Nowakowski, Virginia, Lindner, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914739/
https://www.ncbi.nlm.nih.gov/pubmed/35200148
http://dx.doi.org/10.2196/29124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914739/
https://www.ncbi.nlm.nih.gov/pubmed/35200148
http://dx.doi.org/10.2196/29124

Ejemplares similares